2) For the last 3 years average EPS of Rs 38.11, the PE ratio is … Gland Pharma IPO Subscription Details as on ( 11 Nov 5:00 pm ) The Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.While China's Fosun Pharma Industrial is offering to sell 1.9 crore equity shares, Gland Celsus Bio Chemicals will offload 1 crore shares. Gland Pharma IPO is set to open for public subscription on 9th November 2020 and will remain open till 11th November 2020. The company is managed by Fosun Pharma Industrial Private. 1) On the upper price band of Rs 1,500 and EPS of Rs 49.88 for FY20, the P/E ratio works out to be 30x. The rally of 45 percent in the stock price of Gland Pharma is mind-boggling and this is even as investor subscription for its primary market issue was low. Gland Pharma IPO: Qualified Institutional Buyer: Non-institutional Investor: Retail Individual Investor: Total : Shares Offered: 8,639,394: 6,479,546: 15,118,939 “They infiltrated our borders; now they have taken our money in broad daylight,” was the outburst from a Hyderabad-based pharma industry veteran, on the IPO of Gland Pharma, which is currently trading 50% above its issue price of Rs.1,500. Gland Pharma Limited is launching an IPO on November 9, 2020. Gland Pharma IPO will be the largest IPO of Pharma Industry till Date, after Eris Lifesciences. Gland Pharma IPO GMP Today, Gland Pharma IPO Grey Market Premium Updates | Gland Pharma IPO Listing Gain, Latest target, Opening gain. Gland Pharma IPO. Gland Pharma shares witnessed strong buying interest on November 20 and closed with a 21 percent premium over the issue price on the listing day despite a tepid response to its IPO. Gland Pharma makes allotments to anchor investors, mutual funds Short Note about Gland Pharma Ltd: Gland Pharma is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Gland Pharma IPO listing New Delhi : Gland Pharma shares made a decent debut on stock exchages on Friday with its shares rising as much as 22% to Rs 1,819.70 on BSE as compared to its issue price of Rs 1,500, within first five minutes of listing. The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020.. Link Intime India Private Ltd is the registrar for the IPO. Isn’t that exciting? Gland Pharma IPO Date, Review, Price Band & Market. Next article Gland Pharma Limited IPO GMP Today, Gland Pharma IPO Grey Market Premium Updates Return on Net Worth (RONW) = 21.2% Net Asset Value = Rs 235.32/Share. Face Value = Rs 1. Options Trading Homepage; Benefits & Risks of Options; Options Pricing Options Basics. Ahead of the IPO, Gland Pharma had raised ₹ 1,944 crore from anchor investors. Shares of the Hyderabad-based drugmaker listed at Rs 1,701 apiece, a 13% a premium to its issue price of Rs 1,500 apiece, according to … Gland Pharma IPO is opening on 9th Nov' 2020. Gland Pharma is set to raise 6,000 crores from the equity market. Price range for Gland Pharma's initial public offer (IPO) was fixed at ₹ 1,490-1,500 per share. Gland Pharma IPO price valuations. After the … Advertisement. Gland Pharma IPO: The public issue will be open for three days, from November 9 to November 11, and the shares will be offered in the price band at Rs 1,490-1,500 per share. Crore. Gland Pharma IPO details: Know launch date, price, allotment & more at Angel Broking. The price band is fixed at 1490-1500 rupees with 10 shares of minimum bid. The Fosun Singapore and Shanghai Fosun Pharma-promoted Gland Pharma aims to raise Rs 6,480 crore from the issue. The IPO floor price is 1490 times, and the cap price is 1500 times the face value. The price band for the offer has been fixed at Rs 1,490-1,500 per share. The initial public offer (IPO) of Hyderabad-based injectable-focused Gland Pharma opened for subscription today with an issue price band of Rs 1,490-1,500 per share. Read more about Gland Pharma IPO: Expensive at a price tag of 30x the FY20 earnings on Business Standard. Gland Pharma lists 1,740 a premium of 14% over the cutoff price of 1,500. Twitter. According to the price band set out for the Gland Pharma IPO, the company’s P/E ratio is 30.07 as mentioned in the table above. Hyderabad-based Gland Pharma Ltd (GLP), backed by Chinese firm Fosun Pharma, will launch its initial public offering (IPO) from November 9-11 (Monday-Wednesday). At the higher price band, Gland Pharma aims to raise Rs 6,479.54 crore via public issue. WhatsApp. Author IPO Guru. Gland Pharma Limited is entering in the capital market with an IPO of [.] Gland Pharma hass set the price band for its initial public offer (IPO) at Rs 1,490-1,500 per share. Hyderabad based Gland Pharma company is about to launch its IPO from 9th November 2020 to 11th November 2020. Ltd and Shanghai Fosun Pharmaceutical (Group) Ltd. Gland Pharma IPO is going to hit the market on 9th November 2020.The company to raise around 6480 crore via IPO. Gland Share Price, Gland Stock Price, Gland Pharma Ltd. Stock/Share prices, Gland Pharma Ltd. Live BSE/NSE, F&O Quote of Gland Pharma Ltd. with Historic price charts for NSE / … Previous article Burger King IPO. For extensive information about the company like promoters, financial data download the report now.